Literature DB >> 21298535

Role of the laparoscopic approach to biliary bypass for benign and malignant biliary diseases: a systematic review.

Zaher Toumi1, Moayad Aljarabah, Basil J Ammori.   

Abstract

BACKGROUND: The laparoscopic approach for biliary bypass surgery is a contemporary management option. This article reviews the evidence available for its role and effectiveness.
METHODS: A computerised search was made of the MEDLINE, PubMed, and EMBASE databases for English language publications from the first report of laparoscopic biliary bypass in 1992 to January 2010.
RESULTS: Some 89 patients featured in 19 reports underwent 89 laparoscopic biliary bypass procedures for benign (n=17) and malignant (n=72) indications. Of those, 52 patients underwent biliary bypass alone, while 37 patients underwent biliary bypass combined with gastric bypass. The procedures included cholecystojejunostomy (n=64), hepaticojejunostomy (n=14), and choledochoduodenostomy (n=11). The overall success rate in achieving resolution of jaundice was 98.9%, with a morbidity rate of 12.3% and a mortality rate of 5.6%. More than one procedure was required in 1.1% of patients to achieve resolution of obstructive jaundice. During a reported median follow-up period of 13 months, obstructive jaundice recurred in none of the patients.
CONCLUSION: The laparoscopic approach to biliary bypass surgery is safe and has a high initial success rate, low reintervention rate, and low morbidity and mortality rates. Longer follow-up data and comparative studies with open surgery and endoscopic stenting are needed.

Entities:  

Mesh:

Year:  2011        PMID: 21298535     DOI: 10.1007/s00464-010-1544-6

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  38 in total

1.  Simultaneous laparoscopic biliary and retrocolic gastric bypass in patients with unresectable carcinoma of the pancreas.

Authors:  J Kuriansky; A Sáenz; E Astudillo; V Cardona; L Fernández-Cruz
Journal:  Surg Endosc       Date:  2000-02       Impact factor: 4.584

Review 2.  A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer.

Authors:  Alessio G Morganti; Mariangela Massaccesi; Giuseppe La Torre; Luciana Caravatta; Adele Piscopo; Rosa Tambaro; Luigi Sofo; Giuseppina Sallustio; Marcello Ingrosso; Gabriella Macchia; Francesco Deodato; Vincenzo Picardi; Edy Ippolito; Numa Cellini; Vincenzo Valentini
Journal:  Ann Surg Oncol       Date:  2009-10-24       Impact factor: 5.344

3.  A comparison of choledochoenteric bypass and cholecystoenteric bypass in patients with biliary obstruction due to pancreatic cancer.

Authors:  A S Rosemurgy; C M Burnett; J A Wasselle
Journal:  Am Surg       Date:  1989-01       Impact factor: 0.688

4.  Surgical bypass versus metallic stent for unresectable pancreatic cancer.

Authors:  D Maosheng; T Ohtsuka; J Ohuchida; K Inoue; K Yokohata; K Yamaguchi; K Chijiiwa; M Tanaka
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

5.  Management of benign biliary strictures: biliary enteric anastomosis vs endoscopic stenting.

Authors:  A Tocchi; G Mazzoni; G Liotta; G Costa; L Lepre; M Miccini; E De Masi; M A Lamazza; E Fiori
Journal:  Arch Surg       Date:  2000-02

6.  Therapeutic, prophylactic, and preresection applications of laparoscopic gastric and biliary bypass for patients with periampullary malignancy.

Authors:  A M Hamade; A Z Al-Bahrani; A M A Owera; A A Hamoodi; G H Abid; O I Bani Hani; S O'Shea; S H Lee; B J Ammori
Journal:  Surg Endosc       Date:  2005-07-21       Impact factor: 4.584

7.  Initial experience with laparoscopic bypass for upper gastrointestinal malignancy: a new option for palliation of patients with advanced upper gastrointestinal tumors.

Authors:  Aamir Z Khan; W F Antony Miles; Krishna K Singh
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2005-08       Impact factor: 1.878

8.  Management of benign biliary strictures by percutaneous interventional radiologic techniques (PIRT).

Authors:  Antonio Ramos-De la Medina; Sanjay Misra; Andrew J Leroy; Michael G Sarr
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Laparoscopy in the management of pancreatic cancer: endoscopic cholecystojejunostomy for advanced disease.

Authors:  S Shimi; S Banting; A Cuschieri
Journal:  Br J Surg       Date:  1992-04       Impact factor: 6.939

10.  Laparoscopic Roux-en-Y choledochojejunostomy for benign biliary disease.

Authors:  Ho-Seong Han; Nam-Joon Yi
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2004-04       Impact factor: 1.719

View more
  5 in total

Review 1.  Laparoscopy in the management of hilar cholangiocarcinoma.

Authors:  Akihiro Cho; Hiroshi Yamamoto; Osamu Kainuma; Yorihiko Muto; Hiroo Yanagibashi; Toru Tonooka; Takahito Masuda
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

2.  Single-incision laparoscopic biliary bypass for malignant obstructive jaundice.

Authors:  Hong Yu; Shuodong Wu; Xiaopeng Yu; Jinyan Han; Dianbo Yao
Journal:  J Gastrointest Surg       Date:  2015-02-21       Impact factor: 3.452

3.  Efficacy of endoscopic self-expandable metal stent placement versus surgical bypass for inoperable pancreatic cancer-related malignant biliary obstruction: a propensity score-matched analysis.

Authors:  Ka Wing Ma; Albert Chi Yan Chan; Wong Hoi She; Kenneth Siu Ho Chok; Wing Chiu Dai; Simon Tsang; Tan To Cheung; Chung Mau Lo
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

4.  Laparoscopic hepaticojejunostomy after bile duct injury.

Authors:  Adolfo Cuendis-Velázquez; Carlos Morales-Chávez; Itzé Aguirre-Olmedo; Fernanda Torres-Ruiz; Martín Rojano-Rodríguez; Luis Fernández-Álvarez; Eduardo Cárdenas-Lailson; Mucio Moreno-Portillo
Journal:  Surg Endosc       Date:  2015-06-20       Impact factor: 4.584

5.  Total laparoscopic Roux-en-Y cholangiojejunostomy for the treatment of biliary disease.

Authors:  Dexing Chen; Andong Zhu; Zhibo Zhang
Journal:  JSLS       Date:  2013-06-25       Impact factor: 2.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.